AF488 Anti-Human CD22 Antibody[BU59]

Introducing the AF488 Anti-Human CD22 Antibody [BU59], a highly advanced and meticulously developed product designed to cater to the specific needs of the scientific community. This antibody, labeled with AF488, offers exceptional specificity and sensitivity in detecting the CD22 antigen in human samples.

The AF488 Anti-Human CD22 Antibody [BU59] is meticulously engineered using cutting-edge technology and rigorous quality control measures to ensure optimal performance and reliability. Its superior specificity enables precise identification and characterization of CD22, a cell surface glycoprotein primarily expressed on B cells.

With its AF488 label, this antibody provides an enhanced fluorescence signal, facilitating accurate and efficient detection of CD22 in various experimental applications. Its exceptional sensitivity allows for the detection of even low levels of CD22 expression, enabling researchers to obtain reliable and reproducible results.

This product is meticulously validated and extensively tested to ensure its exceptional performance across a wide range of applications, including flow cytometry, immunofluorescence, and immunohistochemistry. Its versatility and reliability make it an invaluable tool for researchers in the fields of immunology, oncology, and cell biology.

The AF488 Anti-Human CD22 Antibody [BU59] is supplied in a convenient and user-friendly format, ensuring ease of use and compatibility with various experimental protocols. Its high-quality formulation guarantees long-term stability and consistency, allowing for reliable and reproducible results over time.

In summary, the AF488 Anti-Human CD22 Antibody [BU59] is a highly advanced and meticulously developed product that offers exceptional specificity, sensitivity, and versatility. With its superior performance and reliability, this antibody is an indispensable tool for researchers seeking to unravel the complexities of CD22 biology and its implications in various disease states.